EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Internalizing Psychiatric Symptoms in People With Mosaicism for Trisomy 21

Ruth C Brown iD, Allison D'Aguilar, Quinn Hurshman, Rebekah NailorZee, Timothy P York, George Capone iD, Ananda B Amstadter, Colleen Jackson-Cook

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · 2025

DOI: 10.1002/ajmg.b.33022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2025. Verfasst von Ruth C Brown und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: Down Syndrome, Mosaicism. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People with mosaicism for trisomy 21 have been shown to exhibit many of the same phenotypic traits present in people with non‐mosaic Down syndrome, but with varying symptom severity. However, the behavioral phenotype of people with mosaic Down syndrome (mDS) has not been well characterized. This study aimed to examine the prevalence of self‐report and caregiver‐report symptoms of depression and anxiety among a sample of 62 participants with mDS aged 12–46 and assess their association with the percentage of trisomy 21 in blood and/or buccal mucosa cells. The overall MANCOVA revealed a significant effect of trisomy on the set of internalizing scales, controlling for age and gender ( p = 0.038, partial eta 2 = 0.22). However, follow‐up univariate analyses showed that the initial significant effect of trisomy on fear ( p = 0.049, partial eta 2 = 0.08) did not survive correction for multiple comparisons (adjusted p = 0.300). No other effects were significant. This study highlights the high occurrence of depression and anxiety symptoms in individuals with mDS and the need for routine assessment to optimize their care. It also demonstrates the ability of people with mDS to complete these evaluations, thereby supporting their inclusion in research studies/clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeMosaicismHumansFemaleMaleAdultMiddle AgedAdolescentDepressionChildAnxietyYoung AdultPhenotypeSelf Report

Stichwörter der Autor:innen

anxietydepressionmosaic down syndrometrisomy 21

Autor:innen und Institutionen

  • Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Department of Human & Molecular Genetics, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Kennedy Krieger Institute, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Pathology, Virginia Commonwealth University, Richmond, Virginia, USA.

ORCID-Profile: Ruth C Brown, George Capone

Förderung

  • NCATS NIH HHS
  • NIH HHS
  • NICHD NIH HHS
  • National Institutes of Health

Zitieren

APA

Brown, R. C., D'Aguilar, A., Hurshman, Q., NailorZee, R., York, T. P., Capone, G., Amstadter, A. B., & Jackson-Cook, C. (2025). Internalizing Psychiatric Symptoms in People With Mosaicism for Trisomy 21. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. https://doi.org/10.1002/ajmg.b.33022

Vancouver

Brown RC, D'Aguilar A, Hurshman Q, NailorZee R, York TP, Capone G, et al. Internalizing Psychiatric Symptoms in People With Mosaicism for Trisomy 21. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2025. doi:10.1002/ajmg.b.33022

BibTeX
@article{Brown2025,
  author = {Brown, Ruth C and D'Aguilar, Allison and Hurshman, Quinn and NailorZee, Rebekah and York, Timothy P and Capone, George and Amstadter, Ananda B and Jackson-Cook, Colleen},
  title = {Internalizing Psychiatric Symptoms in People With Mosaicism for Trisomy 21},
  journal = {American Journal of Medical Genetics Part B: Neuropsychiatric Genetics},
  year = {2025},
  doi = {10.1002/ajmg.b.33022}
}
Kostenlos starten →